Hingham, MA, United States of America

Stephen D Gillies

USPTO Granted Patents = 74 


 

Average Co-Inventor Count = 2.4

ph-index = 23

Forward Citations = 1,963(Granted Patents)

Forward Citations (Not Self Cited) = 1,540(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Scituate, MA (US) (1992 - 1997)
  • Hingham, MA (US) (1993 - 1998)
  • Carlisle, MA (US) (1998 - 2024)

Company Filing History:


Years Active: 1992-2025

Loading Chart...
Loading Chart...
Loading Chart...
74 patents (USPTO):

Title: The Innovations of Stephen D Gillies: A Pioneer in Antibody Engineering

Introduction: Stephen D Gillies, based in Hingham, MA, is a prominent inventor with an impressive portfolio showcasing his contributions to the field of biotechnology. With a total of 71 patents, Gillies’ work primarily focuses on innovating recombinant antibodies and immunocytokines, significantly impacting therapeutic applications in medicine.

Latest Patents: Among his latest patents, Gillies has developed "Light chain immunoglobulin fusion proteins and methods of use thereof." This patent offers recombinant antibodies that consist of peptides fused to the C-terminus of the light chain constant region, enhancing the potential activity of these antibodies. Another significant patent is for "TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo." This invention includes antibodies specific to various antigens, bispecific antibodies, and immunocytokines, along with methods of treatment, use, and pharmaceutical compositions related to these advancements.

Career Highlights: Throughout his career, Stephen Gillies has made considerable strides in the biotechnology industry. He has worked for notable companies such as Merck KGaA and EMD Lexigen Research Center Corporation, where he has been part of groundbreaking projects that contribute to scientific advancement.

Collaborations: Collaboration has played a vital role in Gillies' success. He has worked alongside talented individuals like Kin-Ming Lo and Anita Anne Hamilton, which highlights the value of teamwork in achieving innovative breakthroughs in the field.

Conclusion: Stephen D Gillies is an exemplary figure in the realm of biotech innovations. His extensive patent portfolio and collaborative spirit underscore his dedication to advancing medical science, particularly in the development of therapeutic antibodies and immunocytokines. As the field of biotechnology continues to evolve, the contributions of inventors like Gillies will undoubtedly pave the way for new treatment possibilities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…